Founded in 2007, HeartFlow is a healthcare technology company positioned at the intersection of AI and healthcare to transform how heart disease is diagnosed and treated. The company’s technology provides a non-invasive, personalized cardiac test that assesses coronary artery disease and allows physicians to determine the appropriate treatment plan.

Investment Rationale

  • Large addressable market for the leading cause of death worldwide
  • Superior technology that allows for a non-invasive and safer diagnostic
  • Improved clinical outcomes and cost reduction

Key Value Add Areas

  • Team & Board
  • Strategic Planning
  • Sales & Marketing
  • Martis Ecosystem


Redwood City, CA

Investment Date:

Dec 2011


Healthcare Technology